30283190|t|Anesthetic Management in Corpus Callosum Agenesis.
30283190|a|Corpus callosum agenesis develops when the band which connects the two hemispheres of the brain does not occur in utero. It is associated with prenatal infections, genetic factors, toxic exposures, metabolic disorders, and chromosome errors. Mostly seen clinical features are macrocephaly, microcephaly, seizures, motor retardation, hypotonia, eye anomalies, and facial dysmorphisms. Here, we report a case of corpus callosum agenesis syndrome undergoing upper endoscopy under deep sedation with dexmedetomidine. The main anesthetic concerns are difficulty in airway, respiratory problems, gastric reflux, and interaction of the seizures therapy with general anesthetics.
30283190	25	49	Corpus Callosum Agenesis	Disease	MESH:D061085
30283190	51	75	Corpus callosum agenesis	Disease	MESH:D061085
30283190	249	268	metabolic disorders	Disease	MESH:D008659
30283190	274	291	chromosome errors	Disease	MESH:D025063
30283190	327	339	macrocephaly	Disease	MESH:D058627
30283190	341	353	microcephaly	Disease	MESH:D008831
30283190	355	363	seizures	Disease	MESH:D012640
30283190	365	382	motor retardation	Disease	MESH:D019957
30283190	384	393	hypotonia	Disease	MESH:D009123
30283190	395	408	eye anomalies	Disease	MESH:D005124
30283190	414	433	facial dysmorphisms	Disease	MESH:C565579
30283190	461	494	corpus callosum agenesis syndrome	Disease	MESH:D061085
30283190	547	562	dexmedetomidine	Chemical	MESH:D020927
30283190	619	630	respiratory	Disease	MESH:D012131
30283190	641	655	gastric reflux	Disease	MESH:D005764
30283190	680	688	seizures	Disease	MESH:D012640
30283190	Negative_Correlation	MESH:D020927	MESH:D061085

